Oxford Biomedica completes €68m sale & leaseback of Windrush Court

UK-based gene and cell therapy group Oxford Biomedica has sold its Windrush Court facility in Oxford to Kadans Science Partner for £60 mln (€68 mln).

Would you like to read more? Log in first (top right of the screen) or take a trial.


Latest news

Best read stories